Home Supplements How We Rate Blog
Lentinus edodes

Shiitake Mushroom

Research reviewed: Up until 03/2026

Shiitake Mushroom (Lentinus edodes) is a dietary supplement with 5 published peer-reviewed studies involving 3,800 participants, researched for Immune Support, Cholesterol Management.

5
Studies
3,800
Participants
1998–2018
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Immune Support

Moderate
3 studies 0 of 3 positive 190 participants

Cholesterol Management

Moderate
2 studies 2 of 2 positive 90 participants 1 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

2/5
Randomised
0/5
Double-Blind
2/5
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2015)
52
Study 2 (1998)
98
Study 3 (2011)
40
Study 1 (2018)
60
Study 2 (2013)
30

Research Timeline

When the studies were published

1
1998
1
2011
1
2013
1
2015
1
2018

All Studies

Detailed breakdown of each trial. Click to expand.

Immune Support

1

To assess daily shiitake consumption on human immunity.

2015 52 participants 4 weeks 5-10g dried shiitake mushrooms daily
Human Study RCT Mixed

Study Type

Randomised, dietary intervention

Purpose

To assess daily shiitake consumption on human immunity.

Dose

5-10g dried shiitake mushrooms daily

Participants

52 healthy young adults

Duration

4 weeks

Results

60% more gamma-delta T cell proliferation (p<0.0001) and 2-fold increase in NK-T cells. Both cell types demonstrated greater ability to express activation receptors. Reduced CRP and improved secretory IgA.

How They Measured It

Ex vivo gamma-delta T cell and NK-T cell proliferation, cytokine secretion

Read full study
2

To evaluate lentinan (beta-1,3 glucan from shiitake) in HIV-positive patients.

1998 98 participants 12 weeks Lentinan 2mg IV weekly
Human Study RCT Placebo Mixed

Study Type

Placebo-controlled, randomised trial

Purpose

To evaluate lentinan (beta-1,3 glucan from shiitake) in HIV-positive patients.

Dose

Lentinan 2mg IV weekly

Participants

98 HIV-positive patients

Duration

12 weeks

Results

Lentinan demonstrated immune modulating properties with stabilization of CD4+ counts in treatment-responsive patients. Phase I/II safety established.

How They Measured It

CD4+ cell count, immune markers, viral load

Read full study
3

To investigate oral lentinan (beta-glucan from shiitake mycelium) on immune response in elderly.

2011 40 participants 10 weeks Soluble beta-glucan from shiitake mycelium 1.5g daily
Human Study Placebo Mixed

Study Type

Crossover, placebo-controlled study

Purpose

To investigate oral lentinan (beta-glucan from shiitake mycelium) on immune response in elderly.

Dose

Soluble beta-glucan from shiitake mycelium 1.5g daily

Participants

40 healthy elderly subjects

Duration

10 weeks

Results

Oral lentinan modulated immune response with increased NK cell activity. First controlled trial demonstrating oral lentinan immune effects in healthy elderly population.

How They Measured It

NK cell activity, lymphocyte proliferation, cytokine levels

Read full study

Cholesterol Management

1

To assess hepatoprotective, antioxidant and cholesterol-lowering activities of Lentinus edodes.

2018 60 participants 8 weeks L. edodes supplementation in diet
Animal Study Positive

Study Type

Animal study - controlled

Purpose

To assess hepatoprotective, antioxidant and cholesterol-lowering activities of Lentinus edodes.

Dose

L. edodes supplementation in diet

Participants

60 Wistar rats

Duration

8 weeks

Results

Significant hepatoprotective, antioxidant, and cholesterol-lowering effects. LDL and total cholesterol significantly reduced. Liver enzyme profiles improved.

How They Measured It

Liver enzymes, lipid profiles, oxidative stress markers

Read full study
2

To assess lentinan combined with chemotherapy on immune function in gastric cancer patients.

2013 30 participants 6 weeks Lentinan IV combined with standard chemotherapy
Human Study Positive

Study Type

Clinical trial - cancer support

Purpose

To assess lentinan combined with chemotherapy on immune function in gastric cancer patients.

Dose

Lentinan IV combined with standard chemotherapy

Participants

30 gastric cancer patients

Duration

6 weeks

Results

Significantly improved natural killer cell activity during chemotherapy. Maintained immune function and improved quality of life compared to chemotherapy alone.

How They Measured It

NK cell cytotoxicity, quality of life, chemotherapy tolerability

Read full study

Frequently Asked Questions

Common questions about Shiitake Mushroom research

What does the research say about Shiitake Mushroom?

There are currently 68 peer-reviewed studies on Shiitake Mushroom (Lentinus edodes), involving 3,800 total participants. Research covers Immune support, Cardiovascular health, Liver health and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Shiitake Mushroom?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (4 human studies, 1 animal study), and reported outcomes.

What health goals has Shiitake Mushroom been studied for?

Shiitake Mushroom has been researched for: Immune support, Cardiovascular health, Liver health, Cholesterol management. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Shiitake Mushroom based on human trials?

Yes, 4 out of 68 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.